United Kingdom · Delayed Price · Currency is GBP · Price in GBX GSK plc Statistics
Total Valuation
GSK plc has a market cap or net worth of GBP 76.35 billion. The enterprise value is 96.80 billion.
| Market Cap | 76.35B |
| Enterprise Value | 96.80B |
Important Dates
The last earnings date was Wednesday, October 28, 2026.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | Nov 12, 2026 |
Share Statistics
GSK plc has 4.01 billion shares outstanding. The number of shares has decreased by -1.37% in one year.
| Current Share Class | 4.01B |
| Shares Outstanding | 4.01B |
| Shares Change (YoY) | -1.37% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 84.61% |
| Float | 3.89B |
Valuation Ratios
The trailing PE ratio is 17.85 and the forward PE ratio is 10.25. GSK plc's PEG ratio is 1.79.
| PE Ratio | 17.85 |
| Forward PE | 10.25 |
| PS Ratio | 2.28 |
| PB Ratio | 4.16 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 10.29 |
| P/OCF Ratio | 8.56 |
| PEG Ratio | 1.79 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.28, with an EV/FCF ratio of 13.04.
| EV / Earnings | 22.25 |
| EV / Sales | 2.89 |
| EV / EBITDA | 8.28 |
| EV / EBIT | 9.46 |
| EV / FCF | 13.04 |
Financial Position
The company has a current ratio of 0.86, with a Debt / Equity ratio of 1.30.
| Current Ratio | 0.86 |
| Quick Ratio | 0.55 |
| Debt / Equity | 1.30 |
| Debt / EBITDA | 2.03 |
| Debt / FCF | 3.21 |
| Interest Coverage | 14.37 |
Financial Efficiency
Return on equity (ROE) is 28.27% and return on invested capital (ROIC) is 25.65%.
| Return on Equity (ROE) | 28.27% |
| Return on Assets (ROA) | 9.63% |
| Return on Invested Capital (ROIC) | 25.65% |
| Return on Capital Employed (ROCE) | 20.10% |
| Weighted Average Cost of Capital (WACC) | 5.05% |
| Revenue Per Employee | 501,833 |
| Profits Per Employee | 65,095 |
| Employee Count | 66,841 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 1.42 |
Taxes
In the past 12 months, GSK plc has paid 561.00 million in taxes.
| Income Tax | 561.00M |
| Effective Tax Rate | 10.42% |
Stock Price Statistics
The stock price has increased by +7.69% in the last 52 weeks. The beta is 0.28, so GSK plc's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | +7.69% |
| 50-Day Moving Average | 1,843.42 |
| 200-Day Moving Average | 1,953.57 |
| Relative Strength Index (RSI) | 57.56 |
| Average Volume (20 Days) | 7,750,075 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GSK plc had revenue of GBP 33.54 billion and earned 4.35 billion in profits. Earnings per share was 1.07.
| Revenue | 33.54B |
| Gross Profit | 24.74B |
| Operating Income | 10.25B |
| Pretax Income | 5.38B |
| Net Income | 4.35B |
| EBITDA | 11.49B |
| EBIT | 10.25B |
| Earnings Per Share (EPS) | 1.07 |
Balance Sheet
The company has 2.96 billion in cash and 23.80 billion in debt, with a net cash position of -20.84 billion or -5.20 per share.
| Cash & Cash Equivalents | 2.96B |
| Total Debt | 23.80B |
| Net Cash | -20.84B |
| Net Cash Per Share | -5.20 |
| Equity (Book Value) | 18.36B |
| Book Value Per Share | 4.68 |
| Working Capital | -2.83B |
Cash Flow
In the last 12 months, operating cash flow was 8.92 billion and capital expenditures -1.50 billion, giving a free cash flow of 7.42 billion.
| Operating Cash Flow | 8.92B |
| Capital Expenditures | -1.50B |
| Depreciation & Amortization | 1.25B |
| Net Borrowing | 6.29B |
| Free Cash Flow | 7.42B |
| FCF Per Share | 1.85 |
Margins
Gross margin is 73.76%, with operating and profit margins of 30.54% and 12.97%.
| Gross Margin | 73.76% |
| Operating Margin | 30.54% |
| Pretax Margin | 16.05% |
| Profit Margin | 12.97% |
| EBITDA Margin | 34.26% |
| EBIT Margin | 30.54% |
| FCF Margin | 22.13% |
Dividends & Yields
This stock pays an annual dividend of 0.68, which amounts to a dividend yield of 3.57%.
| Dividend Per Share | 0.68 |
| Dividend Yield | 3.57% |
| Dividend Growth (YoY) | 7.81% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 62.01% |
| FCF Payout Ratio | 37.27% |
| Buyback Yield | 1.37% |
| Shareholder Yield | 4.94% |
| Earnings Yield | 5.60% |
| FCF Yield | 9.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for GSK plc is 2,149.76, which is 12.88% higher than the current price. The consensus rating is "Hold".
| Price Target | 2,149.76 |
| Price Target Difference | 12.88% |
| Analyst Consensus | Hold |
| Analyst Count | 23 |
| Revenue Growth Forecast (3Y) | 3.70% |
| EPS Growth Forecast (3Y) | 4.47% |
Stock Splits
The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.
| Last Split Date | Jul 19, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.8 |
Scores
GSK plc has an Altman Z-Score of 1.99 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.99 |
| Piotroski F-Score | 6 |